15 Jul by Vitaliy Dadalyan Buy Moderna as COVID-19 Vaccine Shows Promising Result; Target Price $112 in a Best-Case Scenario Moderna Inc announced that its experimental COVID-19 vaccine was safe and induced strong immune responses in all 45 healthy adult participants, sending its shares up over 15% in after-hours trading on Tuesday.
